Olpasiran
amgen
[]
promising clinical trial results on phase 2 ocean(a)-dose targeting elevated lipoprotein(a) presented at the american heart association meeting today. #knowlpa #aha22 
The Family Heart Foundation is a patient-driven nonprofit focused on advocacy, research and education of FH and elevated Lipoprotein(a). #KnowFH #KnowLpa